Institute Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.
J Thromb Haemost. 2011 Aug;9(8):1475-82. doi: 10.1111/j.1538-7836.2011.04403.x.
Hemostasis and thrombosis may be important contributors to cognitive decline and dementia. Certain blood markers may assist in diagnosis or management.
To collate evidence for the association of circulating hemostatic variables and dementia or cognitive impairment.
A systematic review of studies describing blood markers of hemostatic function and cognition/dementia. Abstracts were reviewed by two independent assessors and studies selected based on pre-specified criteria. We described methodological quality and performed meta-analyzes where data allowed.
From 7103 titles, 485 abstracts and included 21 studies (n = 32,773) were assessed. In two longitudinal studies, the incident of vascular dementia risk was greater for higher D-dimer [hazard ratio (HR): 1.50, 95% confidence interval (CI): 1.15-1.96]. For case-control data, we calculated standardized mean differences (SMD) and 95% CI. Higher levels of: factor (F)VII (SMD: 0.93; 95% CI: 0.60-1.26), fibrinogen (SMD: 1.53; 95% CI: 1.17-1.87), prothrombin fragment 1 and 2 (SMD: 0.64; 95% CI: 0.32-0.96), plasminogen activator inhibitor (SMD: 0.68; 95% CI: 0.26-1.10), D-dimer (SMD: 2.00; 95% CI: 1.59-2.40) and von Willebrand factor (VWF) (SMD: 1.68; 95% CI: 1.30-2.06) showed modest but significant associations with vascular dementia. For patients with any dementia diagnosis, associations were with higher D-dimer (SMD: 0.36; 95% CI: 0.15-0.56) and VWF (SMD: 0.31; 95% CI: 0.11-0.51). For specific cognitive domains, significant (P < 0.001) positive correlations were fibrinogen and speed of processing (0.76; 95% CI: 0.67-0.84), verbal memory (0.69; 95% CI: 0.59-0.79) and non-verbal reasoning (0.57; 95% CI: 0.49-0.65).
The present results suggest a modest association between hemostasis and vascular dementia including increased levels of thrombin generation markers (D-dimer and prothrombin fragment 1 + 2) and endothelial dysfunction (VWF and plasminogen activator inhibitor). Associations are weaker for specific cognitive tests and when all dementias are combined.
止血和血栓形成可能是认知能力下降和痴呆的重要原因。某些血液标志物可能有助于诊断或治疗。
整理与凝血变量和痴呆或认知障碍相关的证据。
系统回顾描述止血功能和认知/痴呆血液标志物的研究。两名独立评估员对摘要进行了审查,并根据预先规定的标准选择了研究。我们描述了方法学质量,并在允许的情况下进行了荟萃分析。
从 7103 个标题中,评估了 485 个摘要和包括 21 项研究(n=32773)。在两项纵向研究中,较高的 D-二聚体水平使血管性痴呆风险增加[风险比(HR):1.50,95%置信区间(CI):1.15-1.96]。对于病例对照数据,我们计算了标准化均数差值(SMD)和 95%CI。较高的:因子(F)VII(SMD:0.93;95%CI:0.60-1.26)、纤维蛋白原(SMD:1.53;95%CI:1.17-1.87)、凝血酶原片段 1 和 2(SMD:0.64;95%CI:0.32-0.96)、纤溶酶原激活物抑制剂(SMD:0.68;95%CI:0.26-1.10)、D-二聚体(SMD:2.00;95%CI:1.59-2.40)和血管性血友病因子(VWF)(SMD:1.68;95%CI:1.30-2.06)与血管性痴呆呈中度但显著相关。对于任何痴呆诊断的患者,与较高的 D-二聚体(SMD:0.36;95%CI:0.15-0.56)和 VWF(SMD:0.31;95%CI:0.11-0.51)呈显著相关。对于特定的认知领域,显著(P<0.001)正相关纤维蛋白原和加工速度(0.76;95%CI:0.67-0.84)、言语记忆(0.69;95%CI:0.59-0.79)和非言语推理(0.57;95%CI:0.49-0.65)。
目前的结果表明,止血和血管性痴呆之间存在中度相关性,包括凝血酶生成标志物(D-二聚体和凝血酶原片段 1+2)和内皮功能障碍(VWF 和纤溶酶原激活物抑制剂)水平升高。与特定的认知测试以及当所有痴呆症合并时,相关性较弱。